{
    "2019-07-24": [
        [
            {
                "time": "",
                "original_text": "公司获得买入评级 - 更新中",
                "features": {
                    "keywords": [
                        "公司",
                        "买入评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "“痔疮一哥”马应龙跨界卖口红 美容真的不分上下？",
                "features": {
                    "keywords": [
                        "马应龙",
                        "跨界",
                        "口红",
                        "美容"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-07-24",
                "original_text": "券商首次关注3股并给予买入评级（7月24日）",
                "features": {
                    "keywords": [
                        "券商",
                        "买入评级",
                        "关注"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2019年中报业绩前瞻:医药板块持续分化，寻找景气与避险的交集",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报",
                        "业绩",
                        "景气",
                        "避险"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}